Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/110408
Title: Phenotypic spectrum in recessive STING-associated vasculopathy with onset in infancy : four novel cases and analysis of previously reported cases
Author(s): Wan, RenshengLook up in the Integrated Authority File of the German National Library
Fänder, Johannes
Zakaraia, IaLook up in the Integrated Authority File of the German National Library
[und viele weitere]
Issue Date: 2022
Type: Article
Language: English
Abstract: Gain-of-function variants in the stimulator of interferon response cGAMP interactor 1 (STING1) gene cause STING-Associated Vasculopathy with onset in Infancy (SAVI). Previously, only heterozygous and mostly de novo STING1 variants have been reported to cause SAVI. Interestingly, one variant that only leads to SAVI when homozygous, namely c.841C>T p.(Arg281Trp), has recently been described. However, there are no entries in public databases regarding an autosomal recessive pattern of inheritance. Here, we report four additional unrelated SAVI patients carrying c.841C>T in homozygous state. All patients had interstitial lung disease and displayed typical interferon activation patterns. Only one child displayed cutaneous vasculitis, while three other patients presented with a relatively mild SAVI phenotype. Steroid and baricitinib treatment had a mitigating effect on the disease phenotype in two cases, but failed to halt disease progression. Heterozygous c.841C>T carriers in our analysis were healthy and showed normal interferon activation. Literature review identified eight additional cases with autosomal recessive SAVI caused by c.841C>T homozygosity. In summary, we present four novel and eight historic cases of autosomal recessive SAVI. We provide comprehensive clinical data and show treatment regimens and clinical responses. To date, SAVI has been listed as an exclusively autosomal dominant inherited trait in relevant databases. With this report, we aim to raise awareness for autosomal recessive inheritance in this rare, severe disease which may aid in early diagnosis and development of optimized treatment strategies.
URI: https://opendata.uni-halle.de//handle/1981185920/112363
http://dx.doi.org/10.25673/110408
Open Access: Open access publication
License: (CC BY 4.0) Creative Commons Attribution 4.0(CC BY 4.0) Creative Commons Attribution 4.0
Journal Title: Frontiers in immunology
Publisher: Frontiers Media
Publisher Place: Lausanne
Volume: 13
Original Publication: 10.3389/fimmu.2022.1029423
Page Start: 1
Page End: 14
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
fimmu-13-1029423.pdf2.01 MBAdobe PDFThumbnail
View/Open